BBVA USA Bancshares’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BBVA USA Bancshares’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,907	Closed	-$532K	–	518
2015 Q2	$532K	Sell	12,907 -1,108	-8%	-$39.7K	0.03%	340
2015 Q1	$494K	Buy	14,015 +1,478	+12%	+$50K	0.02%	394
2014 Q4	$403K	Buy	12,537 +674	+6%	+$19.5K	0.02%	433
2014 Q3	$333K	Sell	11,863 -618	-5%	-$18.8K	0.01%	459
2014 Q2	$377K	Buy	12,481 +1,702	+16%	+$47K	0.02%	437
2014 Q1	$298K	Buy	10,779 +53	+0.5%	+$1.39K	0.01%	458
2013 Q4	$274K	Buy	10,726 +2,378	+28%	+$73.3K	0.01%	473
2013 Q3	$249K	Buy	8,348 +786	+10%	+$21.9K	0.01%	463
2013 Q2	$218K	Buy	+7,562	New	+$208K	0.01%	466

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BBVA USA Bancshares's BRLI Position: Q3 2015 in Review

BBVA USA Bancshares sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 12,907 shares — an estimated $532K sold.

BBVA USA Bancshares first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $532K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

BBVA USA Bancshares reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
BBVA USA Bancshares sold 12,907 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $532K.
BBVA USA Bancshares first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
BBVA USA Bancshares's BIO-REFERENCE LABS INC-NEW- position peaked at $532K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BBVA USA Bancshares's 13F filing for Q3 2015, filed 3 Nov 2015.